Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novonix ADR | NVX | Nov 1, 2024 | 1.82 | -0.82 |
NRG Energy | NRG | Nov 1, 2024 | 86.72 | -4.07 |
NRx Pharmaceuticals | NRXP | Nov 1, 2024 | 1.39 | +1.09 |
NSTS Bancorp | NSTS | Nov 1, 2024 | 11.18 | -0.09 |
Nu Holdings | NU | Nov 1, 2024 | 14.34 | -4.97 |
Nu Skin Enterprises | NUS | Nov 1, 2024 | 6.34 | +2.42 |
Nuburu | BURU | Nov 1, 2024 | 0.51 | +13.33 |
NuCana ADR | NCNA | Nov 1, 2024 | 1.54 | -4.94 |
Nucor | NUE | Nov 1, 2024 | 143.56 | +1.21 |
Nukkleus | NUKK | Nov 1, 2024 | 2.27 | +2.16 |
Nurix Therapeutics | NRIX | Nov 1, 2024 | 24.47 | -0.45 |
NuScale Power | SMR | Nov 1, 2024 | 19.01 | -0.68 |
Nustar Energy C Pref | NS-C | Nov 1, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Nov 1, 2024 | 62.55 | +0.72 |
Nutex Health | NUTX | Nov 1, 2024 | 22.60 | +1.39 |
Nutriband | NTRB | Nov 1, 2024 | 5.93 | -4.20 |
Nutrien | NTR | Nov 1, 2024 | 48.36 | +1.43 |
Nuvalent A | NUVL | Nov 1, 2024 | 89.22 | +0.83 |
Nuvation Bio A | NUVB | Nov 1, 2024 | 2.30 | +4.07 |
Nuvectis Pharma | NVCT | Nov 1, 2024 | 6.41 | -14.19 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Nov 1, 2024 | 12.54 | -1.95 |
Nuveen Amtfree Municipal Value Fund | NUW | Nov 1, 2024 | 13.77 | -0.86 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Nov 1, 2024 | 11.43 | -1.47 |
Nuveen Arizona Quality Municipal Fund | NAZ | Nov 1, 2024 | 11.64 | +0.30 |
Nuveen California Amtfree Quality Municipal Income Fund | NKX | Nov 1, 2024 | 13.12 | -0.53 |
Nuveen California Municipal Value Fund | NCA | Nov 1, 2024 | 8.98 | -0.22 |
Nuveen California Quality Municipal Income Fund | NAC | Nov 1, 2024 | 11.42 | -0.44 |
Nuveen California Select Taxfree Income Portfolio | NXC | Nov 1, 2024 | 13.65 | +0.18 |
Nuveen Churchill Direct Lending | NCDL | Nov 1, 2024 | 16.88 | +0.36 |
Nuveen Core Equity Alpha Fund | JCE | Nov 1, 2024 | 14.94 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.